Article Information
History
- March 4, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sydney B. Ross, MSc1,
- Émilie Bortolussi-Courval, NClin2,3,
- Ryan Hanula, BSc2,3,
- Todd C. Lee, MD MPH FIDSA2,3,4,
- Marnie Goodwin Wilson, MD MSc FRCPC*,5 and
- Emily G. McDonald, MD MSc FRCPC*,2,3,6,#
- 1Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada
- 2Centre for Outcomes Research and Evaluation, McGill University Health Centre, Montreal, Quebec, Canada
- 3Division of Experimental Medicine, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada
- 4Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada
- 5Division of General Internal Medicine and Division of Critical Care Medicine, University of British Columbia, Vancouver, British Columbia, Canada
- 6Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada
- ↵#Corresponding Author: Emily G. McDonald MD MSc, emily.mcdonald{at}mcgill.ca, Office 3E.03 5252 De Maisonneuve Boulevard, Montréal, QC, Canada, H4A 3S9
↵* For the purposes of authorship Dr. Wilson and Dr. McDonald contributed equally
Posted March 04, 2022.
COVID-SAFER: Deprescribing Guidance for Nirmatrelvir-ritonavir Drug Interactions in Older Adults
